73 parallel-computing-numerical-methods-"Simons-Foundation" positions at City of Hope
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
, shaping the future of medicine through cutting-edge research. We seek a motivated and talented Postdoctoral Fellow to join Dr. Andrei Rodin’s laboratory in the Department of Computational and Quantitative
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center
-
advance these research goals. Analyze high-throughput sequencing data to identify molecular determinants of cancer progression and therapeutic response. Develop and apply computational pipelines
-
purification, and co-crystallography studies that includes synchrotron data collection, and subsequent structural refinement, fragment-based drug discovery approaches, and computer aided drug discovery methods
-
. Program statistical analyses using statistical software packages. Collaborate with department personnel on research projects, relating statistical methods to medical or biological sciences, in particular
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center
-
overseeing environmental monitoring program of GMP cleanrooms, oversight of microbiological compendial method verification, along with the contamination control program for GMP Manufacturing of cell and gene
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center
-
the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center